Clinical measurement ontology
4163 terms(s) returned
| Term Type: | Record: 2851 to 2900 of 4163 Records | Page: 58 of 84, First Previous Next Last | Show Records Per Page |
- percentage of study population displaying myeloid leukemia at a point in time
- percentage of study population displaying pituitary gland hyperplastic lesions at a point in time
- percentage of study population displaying pituitary tumors at a point in time
- percentage of study population displaying poorly differentiated malignant colorectal tumors at a point in time
- percentage of study population displaying prostate tumorous lesions at a point in time
- percentage of study population displaying prostate tumors at a point in time
- percentage of study population displaying pyometritis at a point in time
- percentage of study population displaying relapsing-remitting experimental autoimmune encephalomyelitis at a point in time
- percentage of study population displaying retinopathy at a point in time
- percentage of study population displaying spleen fibrosis at a point in time
- percentage of study population displaying stomach tumors at a point in time
- percentage of study population displaying testis tumors at a point in time
- percentage of study population displaying trigeminal nerve neurilemmomas at a point in time
- percentage of study population displaying type 1 diabetes mellitus at a point in time
- percentage of study population displaying type 2 diabetes mellitus at a point in time
- percentage of study population displaying unilateral left-sided renal agenesis at a point in time
- percentage of study population displaying unilateral renal agenesis at a point in time
- percentage of study population displaying ventral prostate tumorous lesions at a point in time
- percentage of study population displaying well differentiated malignant colorectal tumors at a point in time
- percentage of study population with hydronephrosis developing hematuria during a period of time
- percentage of study population with hydronephrosis displaying hematuria at a point in time
- pericardium ribonucleic acid level
- peripheral nervous system measurement
- peripheral nervous system molecular composition measurement
- peripheral nervous system morphological measurement
- peripheral nervous system ribonucleic acid composition measurement
- peripheral nervous system ribonucleic acid level
- peripheral retina horizontal cell count to area ratio
- peripheral retina rod bipolar cell count to area ratio
- phenylephrine response/sensitivity measurement
- phenylephrine-induced blood vessel contractile force expressed as percent of contractile force generated by potassium chloride
- phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline
- photopic A wave amplitude of ERG waveform
- photopic B wave amplitude of ERG waveform
- photoreceptor inner segment layer thickness
- pigmented coat/hair area to total coat/hair area ratio
- pigmented dorsal coat/hair area to total dorsal coat/hair area ratio
- pigmented ventral coat/hair area to total ventral coat/hair area ratio
- pineal body ribonucleic acid level
- pituicyte count
- pituicyte measurement
- pituitary gland dry weight
- pituitary gland hyperplastic lesion incidence/prevalence measurement
- pituitary gland hyperplastic lesion measurement
- pituitary gland measurement
- pituitary gland morphological measurement
- pituitary gland ribonucleic acid level
- pituitary gland tumorous lesion incidence/prevalence measurement
- pituitary gland tumorous lesion measurement
- pituitary gland weight
